Literature DB >> 16153141

Herb-drug interactions: interactions between kava and prescription medications.

Rubin Bressler1.   

Abstract

Patients over age 50 typically present with one chronic disease per decade. Each chronic disease usually requires long-term drug therapy, meaning most older patients require several drugs to control their conditions and/or maintain their health. Simultaneously, the use of complementary and alternative medications (CAM) has increased in the United States over the last 20 years, reaching 36% in 2002; herbal medicine use accounts for approximately 22% of all CAM use. Older adults often add herbal medicines to medications prescribed by their physicians, yet do not always inform the physician. The drug metabolizing enzyme systems process all compounds foreign to the body including prescription drugs and herbal medications. Therefore use of both medicinals simultaneously has a potential for interactions of an adverse nature. This review, which will discuss kava, is one in a series covering the documented interactions between herbal medicines with proven efficacy and prescription drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153141

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  12 in total

1.  Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract.

Authors:  Natasha P Clayton; Katsuhiko Yoshizawa; Grace E Kissling; Leo T Burka; Po-Chuen Chan; Abraham Nyska
Journal:  Exp Toxicol Pathol       Date:  2006-10-23

Review 2.  Gene expression profiling as an initial approach for mechanistic studies of toxicity and tumorigenicity of herbal plants and herbal dietary supplements.

Authors:  Lei Guo; Nan Mei; Qingsu Xia; Tao Chen; Po-Chuen Chan; Peter P Fu
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2010-01       Impact factor: 3.781

3.  Ginkgo biloba extract induces gene expression changes in xenobiotics metabolism and the Myc-centered network.

Authors:  Lei Guo; Nan Mei; Wayne Liao; Po-Chuen Chan; Peter P Fu
Journal:  OMICS       Date:  2010-02

4.  Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava.

Authors:  Mamta Behl; Abraham Nyska; Rajendra S Chhabra; Gregory S Travlos; Laurene M Fomby; Barney R Sparrow; Milton R Hejtmancik; Po C Chan
Journal:  Food Chem Toxicol       Date:  2011-08-18       Impact factor: 6.023

5.  Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.

Authors:  Yan Li; Hu Mei; Qiangen Wu; Suhui Zhang; Jia-Long Fang; Leming Shi; Lei Guo
Journal:  Toxicol Sci       Date:  2011-09-09       Impact factor: 4.849

6.  Gene expression profiling in male B6C3F1 mouse livers exposed to kava identifies--changes in drug metabolizing genes and potential mechanisms linked to kava toxicity.

Authors:  Lei Guo; Qiang Shi; Stacey Dial; Qingsu Xia; Nan Mei; Quan-zhen Li; Po-Chuen Chan; Peter Fu
Journal:  Food Chem Toxicol       Date:  2009-12-03       Impact factor: 6.023

7.  An onco-informatics database for anticancer drug interactions with complementary and alternative medicines used in cancer treatment and supportive care: an overview of the OncoRx project.

Authors:  Kevin Yi-Lwern Yap; En Yi Kuo; Jonathan Jun Jie Lee; Wai Keung Chui; Alexandre Chan
Journal:  Support Care Cancer       Date:  2009-09-09       Impact factor: 3.603

8.  Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract.

Authors:  Lei Guo; Quanzhen Li; Qingsu Xia; Stacey Dial; Po-Chuen Chan; Peter Fu
Journal:  Food Chem Toxicol       Date:  2008-12-07       Impact factor: 6.023

Review 9.  Toxicity of kava kava.

Authors:  Peter P Fu; Qingsu Xia; Lei Guo; Hongtao Yu; Po-Chuen Chan
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2008 Jan-Mar       Impact factor: 3.781

10.  Elucidation of danzhixiaoyao wan and its constituent herbs on antioxidant activity and inhibition of nitric oxide production.

Authors:  Hui Liao; Linda K Banbury; David N Leach
Journal:  Evid Based Complement Alternat Med       Date:  2007-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.